Autori: Barratt Jonathan
| Naslov | Safety of Roxadustat Versus Erythropoiesis-Stimulating Agents in Patients with Anemia of Non-dialysis-Dependent or Incident-to-Dialysis Chronic Kidney Disease: Pooled Analysis of Four Phase 3 Studies (Article) |
| Autori | Barratt Jonathan Dellanna Frank Portoles Jose Choukroun Gabriel De Nicola Luca Young James Dimkovic Nada B Reusch Michael |
| Info | ADVANCES IN THERAPY, (2023), vol. 40 br. 4, str. 1546-1559 |
| Projekat | Astellas Pharma, Inc.; Astellas Pharma, Inc. [DOLOMITES: NCT02021318]; FibroGen, Inc. [SIERRAS: NCT02273726, HIMALAYAS: NCT02052310]; AstraZeneca [ROCKIES: NCT02174731] |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science |
     |
| Naslov | Safety of Roxadustat Versus Erythropoiesis-Stimulating Agents in Patients with Anemia of Non-dialysis-Dependent or Incident-to-Dialysis Chronic Kidney Disease: Pooled Analysis of Four Phase 3 Studies (Article) |
| Autori | Barratt Jonathan Dellanna Frank Portoles Jose Choukroun Gabriel De Nicola Luca Young James Dimkovic Nada B Reusch Michael |
| Info | ADVANCES IN THERAPY, (2023), vol. 40 br. 4, str. 1546-1559 |
| Projekat | Astellas Pharma, Inc. (DOLOMITES); FibroGen, Inc.; AstraZeneca; [NCT02021318]; [NCT02273726]; [NCT02052310]; [NCT02174731] |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: |
|
|
| Naslov | Cardiovascular Safety of Roxadustat Versus Erythropoiesis-Stimulating Agents for Treatment of Anemia in Patients With Chronic Kidney Disease Incident to or Not Receiving Dialysis: Pooled Subgroup Analysis of Four Phase 3 Studies (Meeting Abstract) |
| Autori | Esposito Ciro Barratt Jonathan Dellanna Frank Portoles Jose Choukroun Gabriel De Nicola Luca Reusch Michael Young James Jiletcovici Alina Dimkovic Nada B |
| Info | SWISS MEDICAL WEEKLY, (2022), vol. 152 br. , Suppl. 266, str. 23S-24S |
| Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|
|
| Naslov | Iron Parameters in Patients Treated With Roxadustat for Anemia Associated With Chronic Kidney Disease: Post Hoc Analysis of the Non-Dialysis-Dependent or Incident Dialysis Population From Four Phase 3 Studies (Meeting Abstract) |
| Autori | Esposito Ciro Barratt Jonathan Dellanna Frank Portoles Jose Choukroun Gabriel De Nicola Luca Reusch Michael Young James Jiletcovici Alina Dimkovic Nada B |
| Info | SWISS MEDICAL WEEKLY, (2022), vol. 152 br. , Suppl. 266, str. 14S-14S |
| Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|
|
| Naslov | Safety of Roxadustat Versus Erythropoiesis-Stimulating Agents for Treatment of Anemia in Patients with Chronic Kidney Disease Incident to Or Not Receiving Dialysis: Pooled Analysis of Four Phase 3 Studies (Meeting Abstract) |
| Autori | Barratt Jonathan Dellanna Frank Portoles Jose Choukroun Gabriel De Nicola Luca Reusch Michael Young James Dimkovic Nada B |
| Info | NEPHROLOGY DIALYSIS TRANSPLANTATION, (2022), vol. 37 br. , Suppl. 3, str. I387-I388 |
| Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|
|
| Naslov | Roxadustat for the treatment of anaemia in chronic kidney disease patients not on dialysis: A Phase 3, randomised, open-label, active-controlled study (DOLOMITES) (vol 36, pg 1616, 2021) (Correction) |
| Autori | Barratt Jonathan Andric Branislav R Tataradze Avtandil Schomig Michael Reusch Michael Valluri Udaya Mariat Christophe |
| Info | NEPHROLOGY DIALYSIS TRANSPLANTATION, (2022), vol. 37 br. 4, str. 805-805 |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science |
|
|
| Naslov | Pooled efficacy and cardiovascular safety results of roxadustat compared with placebo/ darbepoetin alfa for treatment of anaemia in patients with non-dialysis-dependent (NDD) chronic kidney disease (CKD) (Meeting Abstract) |
| Autori | Barratt Jonathan Dimkovic Nada B Shutov Evgeny Sulowicz Wladyslaw Esposito Ciro Reusch Michael Young James Mariat Christophe |
| Info | SWISS MEDICAL WEEKLY, (2021), vol. 151 br. , Suppl. 256, str. 25S-25S |
| Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|
|
| Naslov | Cardiovascular outcomes associated with achieved haemoglobin level and preliminary rate of rise of haemoglobin in pooled phase 3 studies of roxadustat in non-dialysis-dependent patients with anaemia (Meeting Abstract) |
| Autori | Barratt Jonathan Sulowicz Wladyslaw Cockburn Elinor Reusch Michael Young James Dimkovic Nada B |
| Info | SWISS MEDICAL WEEKLY, (2021), vol. 151 br. , Suppl. 256, str. 7S-7S |
| Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|
|
| Naslov | Roxadustat for the treatment of anaemia in chronic kidney disease patients not on dialysis: a Phase 3, randomized, open-label, active-controlled study (DOLOMITES) (Article) |
| Autori | Barratt Jonathan Andric Branislav R Tataradze Avtandil Schoemig Michael Reusch Michael Valluri Udaya Mariat Christophe |
| Info | NEPHROLOGY DIALYSIS TRANSPLANTATION, (2021), vol. 36 br. 9, str. 1616-1628 |
| Projekat | Astellas Pharma, Inc.Astellas Pharmaceuticals |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|
|
| Naslov | Pooled Efficacy and Cardiovascular Safety Results of 3 Placebo-Controlled and 1 Darbepoetin Alfa-Controlled Studies of Roxadustat for Treatment of Anaemia in Patients with Non-Dialysis-Dependent Chronic Kidney Disease (Meeting Abstract) |
| Autori | Barratt Jonathan Dimkovic Nada B Shutov Evgeny Sulowicz Wladyslaw Esposito Ciro Reusch Michael Young James Mariat Christophe |
| Info | NEPHROLOGY DIALYSIS TRANSPLANTATION, (2021), vol. 36 br. , Suppl. 1, str. - |
| Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|
|
